Analogs of 5-(substituted benzylidene)hydantoin as inhibitors of tyrosinase and melanin formation

Biochimica et Biophysica Acta - General Subjects

Volumn 1810, Issue 6, 2011, Pages 612-619

  Ha, Young Mi ^a   Kim, Jin Ah ^a   Park, Yun Jung ^a   Park, Daeui ^a   Kim, Ji Min ^a   Chung, Ki Wung ^a   Lee, Eun Kyeong ^a,b   Park, Ji Young ^a   Lee, Ji Yeon ^a   Lee, Hye Jin ^a   Yoon, Jeong Hyun ^a   Moon, Hyung Ryong ^a   Chung, Hae Young ^a  

^a Pusan National University   (South Korea)

^b Dongnam Institute of Radiological and Medical Science   (South Korea)

Author keywords

5 (substituted benzylidene)hydantoin derivatives; Antimelanogenesis; Docking study with mushroom tyrosinase; Tyrosinase inhibitory activity

Indexed keywords

5 (2 HYDROXYBENZYLIDENE)IMIDAZOLIDINE 2,4 DIONE; 5 (2,4 DIMETHOXYBENZYLIDENE)IMIDAZOLIDINE 2,4 DIONE; 5 (3 ETHOXY 4 HYDROXYBENZYLIDENE)IMIDAZOLIDINE 2,4 DIONE; 5 (3 HYDROXY 4 METHOXYBENZYLIDENE)IMIDAZOLIDINE 2,4 DIONE; 5 (3,4 DIHYDROXYBENZYLIDENE)IMIDAZOLIDINE 2,4 DIONE; 5 (3,4 DIMETHOXYBENZYLIDENE)IMIDAZOLIDINE 2,4 DIONE; 5 (3,4,5 TRIMETHOXYBENZYLIDENE)IMIDAZOLIDINE 2,4 DIONE; 5 (4 HYDROXY 3 METHOXYBENZYLIDENE)IMIDAZOLIDINE 2,4 DIONE; 5 (4 HYDROXY 3,5 DIMETHOXYBENZYLIDENE)IMIDAZOLIDINE 2,4 DIONE; 5 (4 HYDROXYBENZYLIDENE)IMIDAZOLIDINE 2,4 DIONE; 5 (4 METHOXYBENZYLIDENE)IMIDAZOLIDINE 2,4 DIONE; DEPIGMENTING AGENT; HYDANTOIN DERIVATIVE; KOJIC ACID; MELANIN; MONOPHENOL MONOOXYGENASE; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL MODIFICATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME CONFORMATION; ENZYME INHIBITION; ENZYME INHIBITOR COMPLEX; HORMONE INHIBITION; HYPERPIGMENTATION; INHIBITION KINETICS; MASS SPECTROMETRY; MELANOGENESIS; MELANOMA B16; MOLECULAR DOCKING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SIMULATION; STRUCTURE ACTIVITY RELATION;

AGARICALES; BENZYLIDENE COMPOUNDS; CELL SURVIVAL; CELLS, CULTURED; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; ENZYME ACTIVATION; ENZYME INHIBITORS; HYDANTOINS; INHIBITORY CONCENTRATION 50; MAGNETIC RESONANCE SPECTROSCOPY; MELANINS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; MONOPHENOL MONOOXYGENASE;

BASIDIOMYCOTA;

EID: 79957528363     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2011.03.001     Document Type: Article

References (47)

1. C.J. Cooksey, P.J. Garratt, E.J. Land, S. Pavel, C.A. Ramsden, P.A. Riley, and N.P. Smit Evidence of the indirect formation of the catecholic intermediate substrate responsible for the autoactivation kinetics of tyrosinase J. Biol. Chem. 272 1997 26226 26235 (Pubitemid 27458833)
2. I. Kubo, I. Kinst-Hori, S.K. Chaudhuri, Y. Kubo, and Y.T. Ogura Flavonols from Heterotheca inuloides: tyrosinase inhibitory activity and structural criteria Bioorg. Med. Chem. 8 2000 1749 1755 (Pubitemid 30427241)
3. K. Urabe, J. Nakayama, and Y. Hori J.J. Norlund, R.E. Boissy, V.J. Hearing, R.A. King, J.P. Ortonne, The Pigmentary System: Physiology and Pathophysiology 1998 Oxford University Press New York 909 911
4. M.K. Cullen J.J. Norlund, R.E. Boissy, V.J. Hearing, R.A. King, J.P. Ortonne, The Pigmentary System: Physiology and Pathophysiology 1998 Oxford University Press New York 760 766
5. S. Briganti, E. Camera, and M. Picardo Chemical and instrumental approaches to treat hyperpigmentation Pigment Cell Res. 16 2003 101 110 (Pubitemid 36596955)
6. D.S. Kim, S.Y. Kim, S.H. Park, Y.G. Choi, S.B. Kwon, M.K. Kim, J.I. Na, S.W. Youn, and K.C. Park Inhibitory effects of 4-n-butylresorcinol on tyrosinase activity and melanin synthesis Biol. Pharm. Bull. 28 2005 2216 2219
7. S. Parvez, M. Kang, H.S. Chung, and H. Bae Naturally occurring tyrosinase inhibitors: mechanism and applications in skin health, cosmetics and agriculture industries Phytother. Res. 21 2007 805 816 (Pubitemid 47407639)
8. F. Solano, S. Briganti, M. Picardo, and G. Ghanem Hypopigmenting agents: an updated review on biological, chemical and clinical aspects Pigment Cell Res. 19 2006 550 571 (Pubitemid 44674109)
9. L. Lemic-Stoicevic, A.H. Nias, and A.S. Breathnach Effect of azelaic acid on melanoma cells in culture Exp. Dermatol. 4 1995 79 81
10. J.R. Ros, J.N. Rodriguez-Lopes, and F. Garcia-Canovas Effect of l-ascorbic acid on the monophenolase activity of tyrosinase Biochem. J. 295 1993 309 312 (Pubitemid 23298342)
11. K. Maeda, and M. Fukuda Arbutin: mechanism of its depigmenting action in human melanocyte culture J. Pharmacol. Exp. Ther. 276 1996 765 769 (Pubitemid 126660519)
12. G. Battaini, E. Monzani, L. Casella, L. Santagostini, and R. Pagliarin Inhibition of the catecholase activity of biomimetic dinuclear copper complexes by kojic acid J. Biol. Inorg. Chem. 5 2000 262 268 (Pubitemid 30249409)
13. K. Ohguchi, T. Tanaka, T. Ito, M. Iinuma, K. Matsumoto, Y. Akao, and Y. Nozawa Inhibitory effects of resveratrol derivatives from dipterocarpaceae plants on tyrosinase activity Biosci. Biotechnol. Biochem. 67 2003 1587 1589 (Pubitemid 39251801)
14. N.H. Shin, S.Y. Ryu, E.J. Choi, S.H. Kang, I.M. Chang, K.R. Min, and Y.S. Kin Oxyresveratrol as the potent inhibitor on dopa oxidase activity of mushroom tyrosinase Biochem. Biophys. Res. Commun. 243 1998 801 803 (Pubitemid 28414161)
15. Y.M. Kim, J. Yun, C.K. Lee, H. Lee, K.R. Min, and Y. Kim Oxyresveratrol and hydroxystilbene compounds. Inhibitory effect on tyrosinase and mechanism of action J. Biol. Chem. 277 2002 16340 16344 (Pubitemid 34967923)
16. K. Ohguchi, T. Tanaka, I. Iliya, T. Ito, M. Iinuma, K. Matsumoto, Y. Akao, and Y. Nozawa Gnetol as a potent tyrosinase inhibitor from genus Gnetum Biosci. Biotechnol. Biochem. 67 2003 663 665 (Pubitemid 39251971)
17. J.S. Roh, J.Y. Han, J.H. Kim, and J.K. Hwang Inhibitory effects of active compounds isolated from safflower (Carthamus tinctorius L.) seeds for melanogenesis Biol. Pharm. Bull. 27 2004 1976 1978 (Pubitemid 41701574)
18. J.K. No, M.S. Kim, Y.J. Kim, S.J. Bae, J.S. Choi, and H.Y. Chung Inhibition of tyrosinase by protocatechuic aldehyde Am. J. Chin. Med. 32 2004 97 103 (Pubitemid 38967859)
19. Y. Kim, J. No, J. Lee, M. Kim, and H. Chung Antimelanogenic activity of 3,4-dihydroxyacetophenone: inhibition of tyrosinase and MITF Biosci. Biotechnol. Biochem. 70 2006 532 534 (Pubitemid 43289440)
20. Y.J. Kim, J.K. No, J.H. Lee, and H.Y. Chung 4,4'-Dihydroxybiphenyl as a new potent tyrosinase inhibitor Biol. Pharm. Bull. 28 2005 323 327 (Pubitemid 40880017)
21. Y.M. Ha, S.W. Chung, S.H. Song, H.S. Suh, and H.Y. Chung 4-(6-Hydroxy-2-naphthyl)-1,3-bezendiol: a potent, new tyrosinase inhibitor Biol. Pharm. Bull. 30 2007 1711 1715 (Pubitemid 47407692)
22. C. Carmi, A. Cavazzoni, V. Zuliani, A. Lodola, F. Bordi, and P.V. Plazzi 5-benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity Bioorg. Med. Chem. Lett. 16 2006 4021 4025 (Pubitemid 43903211)
23. S.S. Hah, H.M. Kim, R.A. Sumbad, and P.T. Henderson Hydantoin derivative formation from oxidation of 7,8-dihydro-8-oxo-2'-deoxyguanosine (8-oxodG) and incorporation of 14C-labeled 8-oxodG into the DNA of human breast cancer cells Bioorg. Med. Chem. Lett. 15 2005 3627 3631 (Pubitemid 40942072)
24. J. Chinnappa, P.T. Wong, W. Thenmozhiyal, and K. Chui Anticonvulsant activity of phenylmethylenehydantoins: a structure-activity relationship study J. Med. Chem. 47 2004 1527 1535 (Pubitemid 38327476)
25. K.I. Ahmed Synthesis of arylidenehydrazono- and glycopyranosylhydrazino- sulfonylbenzylidene-2,4-imidazolidinediones as potential antiviral and antitumoral agents Carbohydr. Res. 306 1998 567 573
26. T.R. Rodgers, M.P. LaMontagne, A. Markovac, and A.B. Ash Hydantoins as antitumor agents J. Med. Chem. 20 1977 591 594 (Pubitemid 8065725)
27. R.N. Comber, R.C. Reynolds, J.D. Friedrich, R.A. Manguikian, R.W. Buckheit, and J.J.W. Truss 5,5-disubstituted hydantoins: syntheses and anti-HIV activity J. Med. Chem. 35 1992 3567 3572
28. L. Somsak, L. Kovacs, M. Toth, E. Osz, L. Szilagyi, and Z. Gyorgydeak Synthesis of and a comparative study on the inhibition of muscle and liver glycogen phosphorylases by epimeric pairs of d-gluco- and d-xylopyranosylidene- spiro-(thio)hydantoins and N-(d-glucopyranosyl) amides J. Med. Chem. 44 2001 2843 2848 (Pubitemid 32879725)
29. C.W. Bazil, and T.A. Pedley Advances in the medical treatment of epilepsy Annu. Rev. Med. 49 1998 135 162 (Pubitemid 28197446)
30. M.S. Luer Fosphenytoin Neurol. Res. 20 1998 178 182 (Pubitemid 28110485)
31. M. Matsukura, Y. Daiku, K. Ueda, S. Tanaka, T. Igarashi, and N. Minami Synthesis and antiarrhythmic activity of 2,2-dialkyl-1'-(N-substituted aminoalkyl)-spiro-(chroman-4,4'-imidazolidine)-2',5'-diones Chem. Pharm. Bull. 40 1992 1823 1827
32. J. Knabe, J. Baldauf, and A. Ahlhelm Racemates and enantiomers of basic, substituted 5-phenylhydantoins, synthesis and anti-arrhythmic action Pharmazie 52 1997 912 919 (Pubitemid 28010875)
33. J.C. Menendez, M.P. Diaz, C. Bellver, and M.M. Sollhuber ChemInform abstract: synthesis, anticonvulsant and antihypertensive activity of diastereomeric 9,10-dimethoxy-1,3,4,6,7,11b-hexahydrospiro(benzo(a) quinolizin-2,4′-imidazolidine)-2′,5′-diones Eur. J. Med. Chem. 27 1992 61 66
34. G.P. Moloney, A.D. Robertson, G.R. Martin, S. MacLennan, N. Mathews, and S. Dosworth A novel series of 2,5-substituted tryptamine derivatives as vascular 5HT1B/1D receptor antagonists J. Med. Chem. 40 1997 2347 2362 (Pubitemid 27342569)
35. G.P. Moloney, G.R. Martin, N. Mathews, A. Milne, H. Hobbs, and S. Dosworth Synthesis and serotonergic activity of substituted 2, N-benzylcarboxamido-5-(2-ethyl-1-dioxoimidazolidinyl)-N, N-dimethyltryptamine derivatives: novel antagonists for the vascular 5-HT(1B)-like receptor J. Med. Chem. 42 1999 2504 2526 (Pubitemid 29344292)
36. M. Jansen, H. Potschka, C. Brandt, W. Loscher, and G. Dannhardt Hydantoin-substituted 4,6-dichloroindole-2-carboxylic acids as ligands with high affinity for the glycine binding site of the NMDA receptor J. Med. Chem. 46 2003 64 73 (Pubitemid 36050069)
37. K. Last-Barney, W. Davidson, M. Cardozo, L.L. Frye, C.A. Grygon, and J.L. Hopkins Binding site elucidation of hydantoin-based antagonists of LFA-1 using multidisciplinary technologies: evidence for the allosteric inhibition of a protein-protein interaction J. Am. Chem. Soc. 123 2001 5643 5650 (Pubitemid 32904697)
38. C.S. Ananda Kumar, S.B. Benaka Prasad, K. Vinaya, S. Chandrappa, N.R. Thimmegowda, S.R. Ranganatha, S. Sanjay, and K.S. Rangappa Synthesis and antiproliferative activity of substituted diazaspiro hydantoins: a structure-activity relationship study Invest. New Drugs 27 2009 131 139
39. H. Tada, O. Shiho, K. Kuroshima, M. Koyama, and K. Tsukamoto An improved colorimetric assay for interleukin 2 J. Immunol. Meth. 93 1986 157 165 (Pubitemid 17190370)
40. J.K. No, D.Y. Soung, Y.J. Kim, K.H. Shim, Y.S. Jun, S.H. Rhee, T. Yokozawa, and H.Y. Chung Inhibition of tyrosinase by green tea components Life Sci. 65 1999 PL241 PL246
41. D.S. Kim, S.Y. Kim, J.H. Chung, K.H.H. Kim, C. Eun, and K.C. Park Delayed ERK activation by ceramide reduces melanin synthesis in human melanocytes Cell. Signal. 14 2002 779 785
42. M.L. Bilodeau, J.D. Greulich, R.L. Hullinger, C. Bertolotto, R. Ballotti, and O.M. Andrisani BMP-2 stimulates tyrosinase gene expression and melanogenesis in differentiated melanocytes Pigmen. Cell Res. 14 2001 328 336 (Pubitemid 32956358)
43. K. Arnold, L. Bordoli, J. Kopp, and T. Schwede The SWISS-MODEL workspace: a web-based environment for protein structure homology modeling Bioinformatics 22 2006 195 201 (Pubitemid 43205406)
44. R. Rodriguez, G. Chinea, N. Lopez, T. Pons, and G. Vriend Homology modeling, model and software evaluation: three related resources Bioinformatics 14 1998 523 528 (Pubitemid 28416766)
45. D.T. Moustakas, P.T. Lang, S. Pegg, E. Pettersen, I.D. Kuntz, N. Brooijmans, and R.C. Rizzo Development and validation of a modular, extensible docking program: DOCK 5 J. Comput. Aided Mol. Des. 20 2006 601 619 (Pubitemid 46023925)
46. V.J. Hearing, and K. Tsukamoto Enzymatic control of pigmentation in mammals FASEB J. 5 1991 2902 2909 (Pubitemid 21905830)
47. A. Andrawis, and V. Kahn Effect of methimazole on the activity of mushroom tyrosinase Biochem. J. 235 1986 91 96 (Pubitemid 16041977)